News
-
-
PRESS RELEASE
Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance
Medios AG reports 5.8% revenue growth in Q1 2024, reaching €456.2 million. Full-year guidance confirmed, anticipating significant revenue and margin increase. Acquisition of Ceban planned for May 2024 -
-
-
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Medios acquires Dutch market leader in pharmaceutical compounding services
Medios AG acquires Ceban Pharmaceuticals B.V., the Dutch market leader in pharmaceutical compounding services, in a strategic move to expand its business internationally and create a European Specialty Pharma platform
-
Revolutionizing Fire Camps: NUE's Sustainable Power Solutions Shine at USDA Technology & Development Center
-
Save A Train Continues to Innovate with Rail Enrichment
-
Cameron Ashley Building Products Opens Third Location in the Badger State
-
Event Tickets Center is Named Official Secondary Ticketing Reseller Partner for Most Valuable Promotions and the Historic Jake Paul vs. Mike Tyson Fight
-
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect
-
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
-
secunet Security Networks AG successfully holds Annual General Meeting – Broad approval for all proposed resolutions
-
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
AngloGold Ashanti US$9.0m (A$13.5m) Gold Farm-in Agreement
-
2024 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
PR – ICADE – Success of the cash tender offer for a total amount of €350 million
-
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
-
Availability of preparatory documents for the annual general meeting of June 13, 2024
-
Safran’s 2024 Annual General Meeting